FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/102752 [Registered on: 02/02/2026] Trial Registered Prospectively
Last Modified On: 31/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [clinical trial]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study on the effectiveness of two Ayurvedic herbal treatments for relieving urinary tract infection symptoms in adults 
Scientific Title of Study   A comparative clinical trial to evaluate the effectiveness of Varividaryadi Kashaya and Duralabhadi Kashaya in lower urinary tract infection 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Aneesh.M 
Designation  Post Graduate Scholar 
Affiliation  Vishnu Ayurveda College 
Address  Third Semester PG Scholar PG Department of Kayachikitsa Vishnu Ayurveda College Shoranur
Vishnu Ayurveda College near Government press kulapully Pattambi Road Shoranur Kerala 679122
Palakkad
KERALA
679122
India 
Phone  8848431517  
Fax    
Email  draneeshkalarikkal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Midhun C K MD Ayu 
Designation  Associate Professor  
Affiliation  Vishnu Ayurveda College 
Address  Associate Professor PG Department of Kayachikitsa Vishnu Ayurveda College Shoranur
Vishnu Ayurveda College near Government press kulapully Pattambi Road Shoranur Kerala 679122
Palakkad
KERALA
679122
India 
Phone  7902338877  
Fax    
Email  mithunisc@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Midhun C K MD Ayu 
Designation  Associate Professor  
Affiliation  Vishnu Ayurveda College 
Address  Associate Professor PG Department of Kayachikitsa Vishnu Ayurveda College Shoranur
Vishnu Ayurveda College near Government press kulapully Pattambi Road Shoranur Kerala 679122
Palakkad
KERALA
679122
India 
Phone  7902338877  
Fax    
Email  mithunisc@gmail.com  
 
Source of Monetary or Material Support  
Vishnu Ayurveda College Near GOVT Press kulapully, Pattambi road,Shoranur,Palakkad district, kerala.PIN: 679122 
 
Primary Sponsor  
Name  Dr. Aneesh.M 
Address  Third Semester PG Scholar Vishnu Ayurveda College near Government Press Pattambi Road , Shoranur. PIN:679122 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aneesh M  Vishnu Ayurveda Hospital Shoranur  Vishnu Ayurveda Hospital, Near Govt: Press, Kulapully, Pattambi road, Shoranur,Palakkad , Kerala. PIN: 679122
Palakkad
KERALA 
8848431517

draneeshkalarikkal@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE VISHNU AYURVEDA COLLEGE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N390||Urinary tract infection, site notspecified. Ayurveda Condition: MUTRAKRUCCRAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Duralabhadi kashaya, Reference: Bhaisajya ratnavali, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 48(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 15 Days, anupAna/sahapAna: Yes(details: -Sita ( 6gm)), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Varividaryadi kashaya, Reference: Sahasrayogam, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 48(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 15 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Yellow coloured urine,Dysuria,Increased frequency of micturition, Burning micturition, Urgency of micturition,Stranguria, Nocturia, Suprapubic discomfort
4 or more above symptoms will be selected for study. 
 
ExclusionCriteria 
Details  High grade fever,Pregnancy and lactation, Diabetes mellitus, BPH, Urinary Calculi, PID, Foreign body in the urinary tract, Instrumentation of urinary tract,Pyelonephritis, Hydronephrosis, Sepsis, Chronic renal failure, Alcoholism, Acute UTI due to BPH or Urinary calculi 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Other 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
reduction in clinical symptoms of lower urinary tract infection  Baseline, 2 weeks, 3 weeks  
 
Secondary Outcome  
Outcome  TimePoints 
improvement in symptoms, comparative efficacy of both kashayas & safety profile of the intervention  Baseline, 2 weeks, 3 weeks 
 
Target Sample Size   Total Sample Size="52"
Sample Size from India="52" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  11/02/2026 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [draneeshkalarikkal@gmail.com].

  6. For how long will this data be available start date provided 01-01-2029 and end date provided 31-12-2030?
    Response (Others) -  2 years

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  
Lower Urinary Tract Infection (LUTI) is a common clinical condition characterized by dysuria, burning micturition, increased frequency, urgency, and suprapubic discomfort. In Ayurveda, these features closely resemble Pittaja Mutrakrichra. Although antibiotics are the mainstay of modern management, issues such as recurrence, resistance, and adverse effects necessitate safer and effective alternatives.
The present study is a comparative interventional clinical trial aimed at evaluating the effectiveness of Varividaryadi Kashaya and Duralabhadi Kashaya, two classical Ayurvedic formulations indicated in Mutrakrichra. A total of 52 patients aged 18–50 years, fulfilling the diagnostic and inclusion criteria of Lower Urinary Tract Infection, will be randomly allocated into two groups of 26 each. Group A will receive Varividaryadi Kashaya and Group B will receive Duralabhadi Kashaya, both administered orally at a dose of 48 ml twice daily for 15 days, one hour before food.
Assessment will be done on the 0th day, 16th day, and 21st day using both subjective parameters (clinical symptoms and Pittaja Mutrakrichra lakshanas) and objective parameters (urine routine microscopic examination). The outcomes will be statistically analyzed to compare the therapeutic efficacy of both interventions.
This study aims to scientifically validate classical Ayurvedic formulations and identify a safe, effective, and economical treatment option for the management of Lower Urinary Tract Infection.
 
Close